The role of endogenous dynorphin in ethanol-induced state-dependent CPP

Behavioural Brain Research

Volumn 227, Issue 1, 2012, Pages 58-63

  Nguyen, Khanh ^a   Tseng, Andy ^a   Marquez, Paul ^a,b   Hamid, Abdul ^b   Lutfy, Kabirullah ^a,b  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^b CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Alcohol reward; Conditioned place preference (CPP); Endogenous dynorphin; Kappa opioid receptor; Knockout mouse; State dependent

Indexed keywords

ALCOHOL; DYNORPHIN; KAPPA OPIATE RECEPTOR; NORBINALTORPHIMINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEVELOPMENT; DYN GENE; FEMALE; GENE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CONDITIONING, OPERANT; DRUG ADMINISTRATION SCHEDULE; DYNORPHINS; ENKEPHALINS; ETHANOL; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NALTREXONE; NARCOTIC ANTAGONISTS; PROTEIN PRECURSORS; SEX FACTORS; TIME FACTORS;

EID: 81255163679     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.10.035     Document Type: Article

References (30)

1. Gianoulakis C. Endogenous opioids and addiction to alcohol and other drugs of abuse. Curr Top Med Chem 2009, 9(11):999-1015.
2. Oswald L.M., Wand G.S. Opioids and alcoholism. Physiol Behav 2004, 81(2):339-358.
3. Shippenberg T.S., Zapata A., Chefer V.I. Dynorphin and the pathophysiology of drug addiction. Pharmacol Ther 2007, 116(2):306-321.
4. Singh A.N., Srivastava S., Jainar A.K. Pharmacotherapy of chronic alcoholism: a review. Drugs Today (Barc) 1999, 35(1):27-33.
5. Trigo J.M., Martin-Garcia E., Berrendero F., Robledo P., Maldonado R. The endogenous opioid system: a common substrate in drug addiction. Drug Alcohol Depend 2010, 108(3):183-194.
6. Wee S., Koob G.F. The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse. Psychopharmacology (Berl) 2010, 210(2):121-135.
7. Zapata A., Shippenberg T.S. Endogenous kappa opioid receptor systems modulate the responsiveness of mesoaccumbal dopamine neurons to ethanol. Alcohol Clin Exp Res 2006, 30(4):592-597.
8. Lindholm S., Ploj K., Franck J., Nylander I. Repeated ethanol administration induces short- and long-term changes in enkephalin and dynorphin tissue concentrations in rat brain. Alcohol 2000, 22(3):165-171.
9. Nestby P., Schoffelmeer A.N., Homberg J.R., Wardeh G., De Vries T.J., Mulder A.H., et al. Bremazocine reduces unrestricted free-choice ethanol self-administration in rats without affecting sucrose preference. Psychopharmacology (Berl) 1999, 142(3):309-317.
10. Walker B.M., Koob G.F. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence. Neuropsychopharmacology 2008, 33(3):643-652.
11. Bruijnzeel A.W. Kappa-opioid receptor signaling and brain reward function. Brain Res Rev 2009, 62(1):127-146.
12. Przewlocka B., Turchan J., Lason W., Przewlocki R. Ethanol withdrawal enhances the prodynorphin system activity in the rat nucleus accumbens. Neurosci Lett 1997, 238(1-2):13-16.
13. Blednov Y.A., Walker D., Martinez M., Harris R.A. Reduced alcohol consumption in mice lacking preprodynorphin. Alcohol 2006, 40(2):73-86.
14. Cunningham C.L., Noble D. Methamphetamine-induced conditioned place preference or aversion depending on dose and presence of drug. Ann N Y Acad Sci 1992, 654:431-433.
15. Elliott P.J. Place aversion induced by the substance P analogue, dimethyl-C7, is not state dependent: implication of substance P in aversion. Exp Brain Res 1988, 73(2):354-356.
16. Oberling P., Rocha B., Di Scala G., Sandner G. Evidence for state-dependent retrieval in conditioned place aversion. Behav Neural Biol 1993, 60(1):27-32.
17. Swerdlow N.R, van der Kooy D., Koob G.F., Wenger J.R. Cholecystokinin produces conditioned place-aversions, not place-preferences, in food-deprived rats: evidence against involvement in satiety. Life Sci 1983, 32(18):2087-2093.
18. Gremel C.M., Cunningham C.L. Role of test activity in ethanol-induced disruption of place preference expression in mice. Psychopharmacology (Berl) 2007, 191(2):195-202.
19. Chester J.A., Risinger F.O., Cunningham C.L. Ethanol reward and aversion in mice bred for sensitivity to ethanol withdrawal. Alcohol Clin Exp Res 1998, 22(2):468-473.
20. Fidler T.L., Bakner L., Cunningham C.L. Conditioned place aversion induced by intragastric administration of ethanol in rats. Pharmacol Biochem Behav 2004, 77(4):731-743.
21. Sharifi N., Diehl N., Yaswen L., Brennan M.B., Hochgeschwender U. Generation of dynorphin knockout mice. Brain Res Mol Brain Res 2001, 86(1-2):70-75.
22. Takemori A.E., Ho B.Y., Naeseth J.S., Portoghese P.S. Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J Pharmacol Exp Ther 1988, 246(1):255-258.
23. Bebawy D., Marquez P., Samboul S., Parikh D., Hamid A., Lutfy K. Orphanin FQ/nociceptin not only blocks but also reverses behavioral adaptive changes induced by repeated cocaine in mice. Biol Psychiatry 2010, 68(3):223-230.
24. Mitchell J.M., Liang M.T., Fields H.L. A single injection of the kappa opioid antagonist norbinaltorphimine increases ethanol consumption in rats. Psychopharmacology (Berl) 2005, 182(3):384-392.
25. Belknap J.K., Crabbe J.C., Riggan J., O'Toole L.A. Voluntary consumption of morphine in 15 inbred mouse strains. Psychopharmacology (Berl) 1993, 112(2-3):352-358.
26. Broadbent J., Linder H.V., Cunningham C.L. Genetic differences in naloxone enhancement of ethanol-induced conditioned taste aversion. Psychopharmacology (Berl) 1996, 126(2):147-155.
27. Cunningham C.L., Niehus D.R., Malott D.H., Prather L.K. Genetic differences in the rewarding and activating effects of morphine and ethanol. Psychopharmacology (Berl) 1992, 107(2-3):385-393.
28. Kovacs K.M., Szakall I., O'Brien D., Wang R., Vinod K.Y., Saito M., et al. Decreased oral self-administration of alcohol in kappa-opioid receptor knock-out mice. Alcohol Clin Exp Res 2005, 29(5):730-738.
29. Wagner J.J., Terman G.W., Chavkin C. Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus. Nature 1993, 363(6428):451-454.
30. Chefer V.I., Shippenberg T.S. Paradoxical effects of prodynorphin gene deletion on basal and cocaine-evoked dopaminergic neurotransmission in the nucleus accumbens. Eur J Neurosci 2006, 23(1):229-238.